Companion animal vaccines market seen topping $7.4 billion by 2030

The companion animal vaccines market is projected to grow from $5.01 billion in 2026 to $7.41 billion by 2030, according to The Business Research Company. Rising pet ownership, higher spending on pet healthcare and new vaccine technologies are expected to drive demand, with Asia-Pacific poised to be the fastest-growing region.

Why it matters: - Companion animal vaccines help prevent infectious disease in pets and reduce zoonotic risk to humans. - The market’s projected growth signals more spending on preventive veterinary care, clinic capacity and vaccine innovation. - Pet owners are increasingly treating animals like family members, which is pushing routine immunization higher.

What happened: - The Business Research Company released a companion animal vaccines market report covering market size, trends and global forecasts for 2026-2035. - The market is expected to rise from $4.55 billion in 2025 to $5.01 billion in 2026. - The report forecasts the market will reach $7.41 billion by 2030. - The forecast implies a 10.3% compound annual growth rate through 2030. - The report was published June 30, 2026, from London. - Download a free sample of the report.

The details: - The market’s recent growth has been driven by more pet ownership, higher infectious disease incidence in pets, expanded veterinary clinic networks and broader preventive care awareness. - Core vaccination programs for companion animals have also supported adoption. - Companion animal vaccines are biological products that activate the immune system in pets against specific infectious diseases. - The vaccines are used to lower the risk, severity and spread of illness among animals and between animals and humans. - The report says future growth will be supported by demand for personalized pet healthcare, wider pet insurance coverage, investment in recombinant and mRNA vaccine platforms, and veterinary infrastructure expansion in emerging markets. - The report also points to stronger focus on preventing zoonotic diseases. - Key trends identified include combination vaccines, tighter regulatory requirements and pet travel mandates. - View the full companion animal vaccines market report.

Between the lines: - Rising pet healthcare spending is becoming a structural demand driver, not just a temporary trend. - The American Pet Products Association said U.S. veterinary care and product sales grew from $35.9 billion in 2022 to $38.3 billion in 2023. - North America held the largest market share in 2025. - Asia-Pacific is projected to be the fastest-growing region during the forecast period. - The geographic split suggests mature markets are still large, while emerging markets may deliver the fastest percentage gains.

What’s next: - The report expects humanization of pets to keep improving vaccination compliance. - Wider veterinary clinic coverage should make vaccines easier to access. - Combination vaccines may gain ground because they reduce injections and improve adherence. - Regulatory pressure and travel requirements are likely to keep vaccination rates elevated. - The report’s 2026 edition adds market attractiveness scoring, TAM analysis, company scoring matrices, forecasting dashboards, hotspot infographics and updated graphics.

The bottom line: - Companion animal vaccines are moving from a niche veterinary category to a faster-growing global preventive health market with broad tailwinds through 2030.